We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Illustration

High-Sensitivity Neutralizing Antibody Test Detects Strength of Individual Immune Response to COVID-19

A multi-dimensional immune response test that tracks multiple combinations of antibody responses against several different antigens for COVID-19 has been enhanced to include a high-sensitivity neutralizing antibody diagnostic, which makes it possible to assess the strength of an individual’s immune response to the SARS-CoV-2 virus. More...
13 Jul 2021
Image: Co-Diagnostics Receives CE Marking for Direct Saliva SARS-CoV-2 Test (Photo courtesy of Co-Diagnostics, Inc.)

Co-Diagnostics Receives CE Marking for Direct Saliva SARS-CoV-2 Test

Co-Diagnostics, Inc. (Salt Lake City, UT, USA) has obtained regulatory authorization for its Logix Smart SARS-CoV-2 DS (Direct Saliva) to be sold as an in vitro diagnostic (IVD) for the diagnosis of COVID-19 in markets that accept CE markings. More...
12 Jul 2021
Image: Q-POC™ (Photo courtesy of QuantuMDx)

Portable PCR System Compresses Entire Molecular Diagnostic Laboratory into Single Device for COVID-19 Testing at POC

A new portable PCR system compresses an entire molecular diagnostic laboratory into a simple to use, accessible and affordable single device, offering rapid, molecular diagnostic testing at the point of care, with results in approximately 30 minutes. More...
12 Jul 2021
Illustration

Ortho’s Quantitative COVID-19 IgG Antibody Test First to Receive FDA Emergency Use Authorization

Ortho Clinical Diagnostics’ (Raritan, NJ, USA) VITROS Anti-SARS-CoV-2 IgG Quantitative Test has become the first quantitative COVID-19 IgG antibody test to receive US Food and Drug Administration (FDA) Emergency Use Authorization (EUA). More...
12 Jul 2021
Illustration

AACC Advises Against Using Coronavirus Test CT Values to Guide COVID-19 Patient Care

The American Association for Clinical Chemistry (AACC; Washington, DC, USA) has issued a public statement advising against the use of coronavirus test cycle threshold (Ct) values to guide COVID-19 treatment or public health efforts. More...
09 Jul 2021
Illustration

New Technological Breakthrough Can Rapidly Scale up Testing for SARS-CoV-2 RNA to Stop Spread of COVID-19

A new SARS-CoV-2 testing technology that leverages next-generation sequencing (NGS) to massively scale up testing capacity could stop the spread of COVID-19 and future pathogens. More...
05 Jul 2021
Image: BioGX’s Novel, High-Throughput, Direct Sample COVID-19 RT-PCR Test Receives FDA EUA (Photo courtesy of BioGX)

BioGX’s Novel, High-Throughput, Direct Sample COVID-19 RT-PCR Test Receives FDA EUA

BioGX (Birmingham, AL, USA) has been issued an Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) for its breakthrough direct sample addition, Xfree COVID-19 test. More...
02 Jul 2021
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Centrifuge
Centrifuge 5430/ 5430 R
New
Herpes Virus Test
Human Herpes Virus (HHV-6) Real Time PCR Kit